Summary

Venous Stents Market – Scope of Report
TMR’s report on the global Venous Stents market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global Venous Stents market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Venous Stents market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the Venous Stents market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Venous Stents market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Venous Stents market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Venous Stents market.

The report delves into the competitive landscape of the global Venous Stents market. Key players operating in the global Venous Stents market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Venous Stents market profiled in this report.

Key Questions Answered in Global Venous Stents Market Report
• What is the sales/revenue generated by Venous Stents across all regions during the forecast period?
• What are the opportunities in the global Venous Stents market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2034?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Venous Stents Market – Research Objectives and Research Approach
The comprehensive report on the global Venous Stents market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Venous Stents market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Venous Stents market.

ページTOPに戻る

Table of Contents

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Venous Stents Market
4. Market Overview
    4.1. Introduction
        4.1.1. Segment Definition
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Venous Stents Market Analysis and Forecasts, 2020-2034
        4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
    5.1. Epidemiology of Venous Diseases
    5.2. Product Mapping: Venous Stents
    5.3. Clinical Trial Analysis
    5.4. Regulatory Landscape for Venous Stents in Key Regions / Countries
    5.5. Key Industry Events (Partnerships, Collaborations, Product approvals, Mergers and Acquisitions, Funding and investments)
    5.6. Impact of COVID-19 Pandemic
6. Global Venous Stents Market Analysis and Forecasts, By Technology
    6.1. Introduction & Definition
    6.2. Key Findings / Developments
    6.3. Market Value Forecast By Stent Design, 2020-2034
        6.3.1. Iliac Vein Stent Technology
        6.3.2. Wallstent Technology
        6.3.3. Others
    6.4. Market Attractiveness By Technology
7. Global Venous Stents Market Analysis and Forecasts, By Material
    7.1. Introduction & Definition
    7.2. Key Findings / Developments
    7.3. Market Value Forecast By Material, 2020-2034
        7.3.1. Nitinol
        7.3.2. Elgiloy
        7.3.3. Stainless Steel
    7.4. Market Attractiveness By Material
8. Global Venous Stents Market Analysis and Forecasts, By Stent Design
    8.1. Introduction & Definition
    8.2. Key Findings / Developments
    8.3. Market Value Forecast By Stent Design, 2020-2034
        8.3.1. Braided
        8.3.2. Laser-cut
        8.3.3. Open-cell
        8.3.4. Closed-cell
    8.4. Market Attractiveness By Stent Design
9. Global Venous Stents Market Analysis and Forecasts, By Placement of Stent
    9.1. Introduction & Definition
    9.2. Key Findings / Developments
    9.3. Market Value Forecast By Placement of Stent, 2020-2034
        9.3.1. Lower Limbs
        9.3.2. Thorax
        9.3.3. Abdomen
        9.3.4. Upper Limbs
    9.4. Market Attractiveness By Placement of Stent
10. Global Venous Stents Market Analysis and Forecasts, By Indication
    10.1. Introduction & Definition
    10.2. Key Findings / Developments
    10.3. Market Value Forecast By Indication, 2020-2034
        10.3.1. Chronic Deep Vein Thrombosis
        10.3.2. Post Thrombotic Syndrome
        10.3.3. May-Thurner Syndrome
        10.3.4. Nutcracker Syndrome
        10.3.5. Hemodialysis / Arteriovenous Fistulae
        10.3.6. Others
    10.4. Market Attractiveness By Indication
11. Global Venous Stents Market Analysis and Forecasts, By End-user
    11.1. Introduction & Definition
    11.2. Key Findings / Developments
    11.3. Market Value Forecast By End-user, 2020-2034
        11.3.1. Hospitals
        11.3.2. Ambulatory Surgical Centers
        11.3.3. Specialty Centers
        11.3.4. Others
    11.4. Market Attractiveness By End-user
12. Global Venous Stents Market Analysis and Forecasts, By Region
    12.1. Key Findings
    12.2. Market Value Forecast By Region
        12.2.1. North America
        12.2.2. Europe
        12.2.3. Asia Pacific
        12.2.4. Latin America
        12.2.5. Middle East & Africa
    12.3. Market Attractiveness By Region
13. North America Venous Stents Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast By Technology, 2020-2034
        13.2.1. Iliac Vein Stent Technology
        13.2.2. Wallstent Technology
        13.2.3. Others
    13.3. Market Value Forecast By Material, 2020-2034
        13.3.1. Nitinol
        13.3.2. Elgiloy
        13.3.3. Stainless Steel
    13.4. Market Value Forecast By Stent Design, 2020-2034
        13.4.1. Braided
        13.4.2. Laser-cut
        13.4.3. Open-cell
        13.4.4. Closed-cell
    13.5. Market Value Forecast By Placement of Stent, 2020-2034
        13.5.1. Lower Limbs
        13.5.2. Thorax
        13.5.3. Abdomen
        13.5.4. Upper Limbs
    13.6. Market Value Forecast By Indication, 2020-2034
        13.6.1. Chronic Deep Vein Thrombosis
        13.6.2. Post Thrombotic Syndrome
        13.6.3. May-Thurner Syndrome
        13.6.4. Nutcracker Syndrome
        13.6.5. Hemodialysis / Arteriovenous Fistulae
        13.6.6. Others
    13.7. Market Value Forecast By End-user, 2020-2034
        13.7.1. Hospitals
        13.7.2. Ambulatory Surgical Centers
        13.7.3. Specialty Centers
        13.7.4. Others
    13.8. Market Value Forecast By Country, 2020-2034
        13.8.1. U.S.
        13.8.2. Canada
    13.9. Market Attractiveness Analysis
        13.9.1. By Technology
        13.9.2. By Material
        13.9.3. By Stent Design
        13.9.4. By Placement of Stent
        13.9.5. By Indication
        13.9.6. By End-user
        13.9.7. By Country
14. Europe Venous Stents Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast By Technology, 2020-2034
        14.2.1. Iliac Vein Stent Technology
        14.2.2. Wallstent Technology
        14.2.3. Others
    14.3. Market Value Forecast By Material, 2020-2034
        14.3.1. Nitinol
        14.3.2. Elgiloy
        14.3.3. Stainless Steel
    14.4. Market Value Forecast By Stent Design, 2020-2034
        14.4.1. Braided
        14.4.2. Laser-cut
        14.4.3. Open-cell
        14.4.4. Closed-cell
    14.5. Market Value Forecast By Placement of Stent, 2020-2034
        14.5.1. Lower Limbs
        14.5.2. Thorax
        14.5.3. Abdomen
        14.5.4. Upper Limbs
    14.6. Market Value Forecast By Indication, 2020-2034
        14.6.1. Chronic Deep Vein Thrombosis
        14.6.2. Post Thrombotic Syndrome
        14.6.3. May-Thurner Syndrome
        14.6.4. Nutcracker Syndrome
        14.6.5. Hemodialysis / Arteriovenous Fistulae
        14.6.6. Others
    14.7. Market Value Forecast By End-user, 2020-2034
        14.7.1. Hospitals
        14.7.2. Ambulatory Surgical Centers
        14.7.3. Specialty Centers
        14.7.4. Others
    14.8. Market Value Forecast By Country / Sub-region, 2020-2034
        14.8.1. Germany
        14.8.2. U.K.
        14.8.3. France
        14.8.4. Spain
        14.8.5. Italy
        14.8.6. Rest of Europe
    14.9. Market Attractiveness Analysis
        14.9.1. By Technology
        14.9.2. By Material
        14.9.3. By Stent Design
        14.9.4. By Placement of Stent
        14.9.5. By Indication
        14.9.6. By End-user
        14.9.7. By Country / Sub-region
15. Asia Pacific Venous Stents Market Analysis and Forecast
    15.1. Introduction
        15.1.1. Key Findings
    15.2. Market Value Forecast By Technology, 2020-2034
        15.2.1. Iliac Vein Stent Technology
        15.2.2. Wallstent Technology
        15.2.3. Others
    15.3. Market Value Forecast By Material, 2020-2034
        15.3.1. Nitinol
        15.3.2. Elgiloy
        15.3.3. Stainless Steel
    15.4. Market Value Forecast By Stent Design, 2020-2034
        15.4.1. Braided
        15.4.2. Laser-cut
        15.4.3. Open-cell
        15.4.4. Closed-cell
    15.5. Market Value Forecast By Placement of Stent, 2020-2034
        15.5.1. Lower Limbs
        15.5.2. Thorax
        15.5.3. Abdomen
        15.5.4. Upper Limbs
    15.6. Market Value Forecast By Indication, 2020-2034
        15.6.1. Chronic Deep Vein Thrombosis
        15.6.2. Post Thrombotic Syndrome
        15.6.3. May-Thurner Syndrome
        15.6.4. Nutcracker Syndrome
        15.6.5. Hemodialysis / Arteriovenous Fistulae
        15.6.6. Others
    15.7. Market Value Forecast By End-user, 2020-2034
        15.7.1. Hospitals
        15.7.2. Ambulatory Surgical Centers
        15.7.3. Specialty Centers
        15.7.4. Others
    15.8. Market Value Forecast By Country / Sub-region, 2020-2034
        15.8.1. China
        15.8.2. Japan
        15.8.3. India
        15.8.4. Australia & New Zealand
        15.8.5. Rest of Asia Pacific
    15.9. Market Attractiveness Analysis
        15.9.1. By Technology
        15.9.2. By Material
        15.9.3. By Stent Design
        15.9.4. By Placement of Stent
        15.9.5. By Indication
        15.9.6. By End-user
        15.9.7. By Country / Sub-region
16. Latin America Venous Stents Market Analysis and Forecast
    16.1. Introduction
        16.1.1. Key Findings
    16.2. Market Value Forecast By Technology, 2020-2034
        16.2.1. Iliac Vein Stent Technology
        16.2.2. Wallstent Technology
        16.2.3. Others
    16.3. Market Value Forecast By Material, 2020-2034
        16.3.1. Nitinol
        16.3.2. Elgiloy
        16.3.3. Stainless Steel
    16.4. Market Value Forecast By Stent Design, 2020-2034
        16.4.1. Braided
        16.4.2. Laser-cut
        16.4.3. Open-cell
        16.4.4. Closed-cell
    16.5. Market Value Forecast By Placement of Stent, 2020-2034
        16.5.1. Lower Limbs
        16.5.2. Thorax
        16.5.3. Abdomen
        16.5.4. Upper Limbs
    16.6. Market Value Forecast By Indication, 2020-2034
        16.6.1. Chronic Deep Vein Thrombosis
        16.6.2. Post Thrombotic Syndrome
        16.6.3. May-Thurner Syndrome
        16.6.4. Nutcracker Syndrome
        16.6.5. Hemodialysis / Arteriovenous Fistulae
        16.6.6. Others
    16.7. Market Value Forecast By End-user, 2020-2034
        16.7.1. Hospitals
        16.7.2. Ambulatory Surgical Centers
        16.7.3. Specialty Centers
        16.7.4. Others
    16.8. Market Value Forecast By Country / Sub-region, 2020-2034
        16.8.1. Brazil
        16.8.2. Mexico
        16.8.3. Rest of Latin America
    16.9. Market Attractiveness Analysis
        16.9.1. By Technology
        16.9.2. By Material
        16.9.3. By Stent Design
        16.9.4. By Placement of Stent
        16.9.5. By Indication
        16.9.6. By End-user
        16.9.7. By Country / Sub-region
17. Middle East & Africa Venous Stents Market Analysis and Forecast
    17.1. Introduction
        17.1.1. Key Findings
    17.2. Market Value Forecast By Technology, 2020-2034
        17.2.1. Iliac Vein Stent Technology
        17.2.2. Wallstent Technology
        17.2.3. Others
    17.3. Market Value Forecast By Material, 2020-2034
        17.3.1. Nitinol
        17.3.2. Elgiloy
        17.3.3. Stainless Steel
    17.4. Market Value Forecast By Stent Design, 2020-2034
        17.4.1. Braided
        17.4.2. Laser-cut
        17.4.3. Open-cell
        17.4.4. Closed-cell
    17.5. Market Value Forecast By Placement of Stent, 2020-2034
        17.5.1. Lower Limbs
        17.5.2. Thorax
        17.5.3. Abdomen
        17.5.4. Upper Limbs
    17.6. Market Value Forecast By Indication, 2020-2034
        17.6.1. Chronic Deep Vein Thrombosis
        17.6.2. Post Thrombotic Syndrome
        17.6.3. May-Thurner Syndrome
        17.6.4. Nutcracker Syndrome
        17.6.5. Hemodialysis / Arteriovenous Fistulae
        17.6.6. Others
    17.7. Market Value Forecast By End-user, 2020-2034
        17.7.1. Hospitals
        17.7.2. Ambulatory Surgical Centers
        17.7.3. Specialty Centers
        17.7.4. Others
    17.8. Market Value Forecast By Country / Sub-region, 2020-2034
        17.8.1. GCC Countries
        17.8.2. South Africa
        17.8.3. Rest of Middle East & Africa
    17.9. Market Attractiveness Analysis
        17.9.1. By Technology
        17.9.2. By Material
        17.9.3. By Stent Design
        17.9.4. By Placement of Stent
        17.9.5. By Indication
        17.9.6. By End-user
        17.9.7. By Country / Sub-region
18. Competition Landscape
    18.1. Market Player - Competition Matrix (By Tier and Size of companies)
    18.2. Company Profiles
        18.2.1. Becton, Dickinson, and Company (BD)
            18.2.1.1. Company Overview
            18.2.1.2. Financial Overview
            18.2.1.3. Product Portfolio
            18.2.1.4. Business Strategies
            18.2.1.5. Recent Developments
        18.2.2. Medtronic plc
            18.2.2.1. Company Overview
            18.2.2.2. Financial Overview
            18.2.2.3. Product Portfolio
            18.2.2.4. Business Strategies
            18.2.2.5. Recent Developments
        18.2.3. Boston Scientific Corporation
            18.2.3.1. Company Overview
            18.2.3.2. Financial Overview
            18.2.3.3. Product Portfolio
            18.2.3.4. Business Strategies
            18.2.3.5. Recent Developments
        18.2.4. Cook Medical
            18.2.4.1. Company Overview
            18.2.4.2. Financial Overview
            18.2.4.3. Product Portfolio
            18.2.4.4. Business Strategies
            18.2.4.5. Recent Developments
        18.2.5. Koninklijke Philips N.V.
            18.2.5.1. Company Overview
            18.2.5.2. Financial Overview
            18.2.5.3. Product Portfolio
            18.2.5.4. Business Strategies
            18.2.5.5. Recent Developments
        18.2.6. Bentley InnoMed GmbH
            18.2.6.1. Company Overview
            18.2.6.2. Financial Overview
            18.2.6.3. Product Portfolio
            18.2.6.4. Business Strategies
            18.2.6.5. Recent Developments
        18.2.7. W. L. Gore & Associates, Inc.
            18.2.7.1. Company Overview
            18.2.7.2. Financial Overview
            18.2.7.3. Product Portfolio
            18.2.7.4. Business Strategies
            18.2.7.5. Recent Developments
        18.2.8. optimed Medizinische Instrumente GmbH
            18.2.8.1. Company Overview
            18.2.8.2. Financial Overview
            18.2.8.3. Product Portfolio
            18.2.8.4. Business Strategies
            18.2.8.5. Recent Developments
        18.2.9. plus medica GmbH & Co. KG
            18.2.9.1. Company Overview
            18.2.9.2. Financial Overview
            18.2.9.3. Product Portfolio
            18.2.9.4. Business Strategies
            18.2.9.5. Recent Developments
        18.2.10. SUZHOU INNOMED MEDICAL DEVICE CO.,LTD
            18.2.10.1. Company Overview
            18.2.10.2. Financial Overview
            18.2.10.3. Product Portfolio
            18.2.10.4. Business Strategies
            18.2.10.5. Recent Developments